e-SPACE Heart Failure 2023
Published: 25 October 2023
-
Views:
3135
-
Likes:
7
-
Views:
3135
-
Likes:
7
-
36m 3s -
1h 1m 56sPart 2 | Session 2 Plenary session 6 – Iron deficiency: the totality of evidence
-
25m 15s
-
59m 4sPart 2 | Session 4 Plenary session 7 – Managing comorbidities in HF
-
1h 46sPart 2 | Session 5 Plenary session 8 – Devices in HF: time to reassess their place?
-
44m 24s
-
1h 1m 52sPart 2 | Session 7 Plenary session 9 – New technologies for HF management
-
1h 2m 8sPart 2 | Session 8 Plenary session 10 – Special Populations
-
1h 54sPart 1 | Session 1 Plenary session 1 – Recent guideline updates in HF Ahmed Bennis, Frieder Braunschweig, Marco Metra, Alicia Chan, Ovidiu Chioncel, Stefan Anker
-
41m 37sPart 1 | Session 2 Meet the expert – Iron Deficiency & IV Iron – The 2023 ESC HF Guidelines and Recent Trial Results: Interpretation & Implementation (Supported by an unrestricted educational grant from Pharmacosmos) Patricia Campbell, Paul Kalra, Robert Mentz
-
1h 8m 32sPart 1 | Session 3 Plenary session 2 – GDMT in the clinical setting Michael Böhm, Frieder Braunschweig, John JV McMurray, Gianluigi Savarese, Marianna Adamo
-
51m 41sPart 1 | Session 4 Special Live Interactive Session – Management of ATTR-CM Brett Sperry, Arnt Kristen, Fabian Knebel, Ahmad Masri
-
44m 4sPart 1 | Session 5 Meet the expert – Best practices in the management of patients with cardiac amyloidosis (Supported by an educational grant from AstraZeneca) Peter van der Meer, Daniela Tomasoni, Marianna Fontana
-
57m 43sPart 1 | Session 6 Plenary session 3 – SGLT2i in clinical practice Stefan Anker, Clara Saldarriaga, Milton Packer, Shelley Zieroth, Muthiah Vaduganathan, Deepak L Bhatt
-
40m 4sPart 1 | Session 7 Meet the expert – Management of patients with HFpEF: What did we learn from our HFrEF patients (Supported by an educational grant from AstraZeneca) Giuseppe Rosano, Clara Saldarriaga, Gianluigi Savarese
-
1h 1m 49sPart 1 | Session 8 Plenary session 4 – Obesity and weight management in HF Mikhail Kosiborod, Massimo Piepoli, Giulia Ferrannini, Wolfram Doehner, Mark Petrie
Overview
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure 2023.
A thoughtfully curated programme supported the exploration of how leading experts are implementing the new heart failure guidelines into clinical practice and showed the latest information on patient profiling in heart failure for tailoring medical therapy.
This event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Giuseppe Rosano
Consultant Cardiologist and Professor of Cardiology (Hon)
Giuseppe Rosano is Consultant Cardiologist and Professor of Cardiology at St George’s, University of London, UK where he is also the director of MSc Heart Failure.
His research interests focus on experimental and clinical pharmacology, heart failure, cardiac metabolism, diabetes and gender differences in cardiovascular diseases. Prof Rosano has been core member of the Cardiovascular Working Party of the European Medicines Agency and member of the Pricing and Reimbursement Committee of the Italian Drug Agency. He is the President-Elect of the Heart Failure Association Board (HFA), and Chairman of the Education Committee of the HFA. Prof Rosano is on the editorial board for European Journal of Heart Failure, European Heart Journal CV Pharmacotherapy, Cardiac Failure Reviews and Cardiovascular Diabetology. He has authored more than 500 peer…
Gianluigi Savarese
Associate Professor of Cardiology
Dr Gianluigi Savarese is currently an Associate Professor of Cardiology and Heart Failure Specialist at the Karolinska Institute in Stockholm, Sweden.
Dr Savarese has served on the board for the European Society of Cardiology's Heart Failure Association since 2020, and has previously been a Nucleus member of a working group on Cardiovascular Pharmacotherapy for the ESC. He is a member of the Italian Society of Cardiology, and the Swedish Society of Cardiology.
Dr Savarese attended the University of Naples Federico II University for his degree in Surgery and Medicine between 2004 - 2010. He then went on to stay at the same institution until 2016 as he completed his Specialism in Cardiovascular Diseases. He then continued his postgraduate studies at the University of Zurich between 2015-2017, where he continued his studies into Heart Failure. Finally, Dr Savarese completed his PhD at the Karolinska Institutet in 2018.
Dr Savarese…
Ileana L Piña
Dr Ileana L Pina is Professor at the Department of Medicine (Cardiology) and Professor in the Department of Epidemiology and Population Health at Montefiore Einstein Center for Heart and Vascular Care, US.
Dr Piña has a particular research and clinical interest in rehabilitation of heart disease in patients with heart failure. She completed a NHLBI HF ACTION trial and is in the process of examining recovery after exercise which could be translated to an additional parameter that may better predict prognosis of outcomes. In addition, there was a R21 to NHLBI to examine Vitamin D levels as another predictor from the HF ACTION database.
Dr Ileana L Pina is an Editorial Board member of Cardiac Failure Review.
Comments